Hybrid treatment of a giant coronary artery aneurysm in a patient with immunoglobulin G4-related disease.


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 20 01 2021
accepted: 06 06 2021
pubmed: 9 6 2021
medline: 7 8 2021
entrez: 8 6 2021
Statut: ppublish

Résumé

A 62-year-old man was diagnosed with a giant coronary artery aneurysm associated with immunoglobulin G4 (IgG4)-related disease. He had previously undergone two thoracic operations with sternotomies and abdominal aortic aneurysm repair for IgG4-related aortopathy. We opted for hybrid open and endovascular repair to reduce risk and avoid complications of a resternotomy and extracorporeal circulation. This first successful case of hybrid repair of a giant coronary artery aneurysm shows that the procedure is safe and feasible in patients with IgG4-related vasculopathy. It is critical to carefully monitor these patients for the occurrence of new IgG4-related aneurysms and other manifestations of vasculopathy.

Identifiants

pubmed: 34101099
doi: 10.1007/s11748-021-01668-4
pii: 10.1007/s11748-021-01668-4
doi:

Substances chimiques

Immunoglobulin G 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1347-1351

Informations de copyright

© 2021. The Japanese Association for Thoracic Surgery.

Références

Crawley PD, Mahlow WJ, Huntsinger DR, Afiniwala S, Wortham DC. Giant coronary artery aneurysms: review and update. Tex Heart Inst J. 2014;41:603–8.
doi: 10.14503/THIJ-13-3896
Lee WC, Fang HY, Fang CY. Hybrid strategy to treat life-threatening giant coronary artery aneurysm with severe in-stent restenosis. Int Heart J. 2017;58:283–5.
doi: 10.1536/ihj.16-233
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.
doi: 10.1056/NEJMra1104650
Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg. 2009;49:1264–71 (discussion 1271).
doi: 10.1016/j.jvs.2008.11.072
Matsuyama S, Kishigami T, Sakamoto M. A case of giant right coronary artery aneurysm due to IgG4-related disease. Gen Thorac Cardiovasc Surg. 2020;68:1453–6.
doi: 10.1007/s11748-019-01272-7
Nikolaidou CN, Vassiliou VS, Watson WD. Coronary artery aneurysms-a truly rare entity or simply unrecognized so far? Oxf Med Case Rep. 2019;29:omz009.
Li D, Wu Q, Sun L, Song Y, Wang W, Pan S, et al. Surgical treatment of giant coronary artery aneurysm. J Thorac Cardiovasc Surg. 2005;130:817–21.
doi: 10.1016/j.jtcvs.2005.04.004
Kim TH, Marfatia R, Lee J, Azrin M. Giant coronary aneurysm management with Viabahn covered stent. Cardiovasc Revasc Med. 2017;18:56–9.
doi: 10.1016/j.carrev.2017.03.019
Kawsara A, Núñez Gil IJ, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of coronary artery aneurysms. JACC Cardiovasc Interv. 2018;11:1211–23.
doi: 10.1016/j.jcin.2018.02.041
Szalat A, Durst R, Cohen A, Lotan C. Use of polytetrafluoroethylene-covered stent for treatment of coronary artery aneurysm. Catheter Cardiovasc Interv. 2005;66:203–8.
doi: 10.1002/ccd.20448
Stone JH, Khosroshahi A, Hilgenberg A, Spooner A, Isselbacher EM, Stone JR. IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum. 2009;60:3139–45.
doi: 10.1002/art.24798
Sakai K, Watanabe T, Yoshida T. Endovascular treatment of immunoglobulin G4-related inflammatory abdominal aortic aneurysm. J Vasc Surg Cases Innov Tech. 2018;4:189–92.
doi: 10.1016/j.jvscit.2018.03.012
Kasashima S, Kasashima F, Kawashima A, Endo M, Matsumoto Y, Kawakami K. Clinical outcomes after endovascular repair and open surgery to treat immunoglobulin G4-related and nonrelated inflammatory abdominal aortic aneurysms. J Endovasc Ther. 2017;24:833–45.
doi: 10.1177/1526602817732316
Tanigawa J, Daimon M, Takeda Y, Katsumata T, Ishizaka N. Temporal changes in serum IgG4 levels after coronary artery bypass graft surgery. Hum Pathol. 2012;43:2093–5.
doi: 10.1016/j.humpath.2012.07.006

Auteurs

Yuji Kamikawa (Y)

Cardiovascular Surgery Department, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho kita, Kasugai City, Aichi, 487-0016, Japan. y_kami@me.com.
Cardiovascular Surgery Department, Sendai Tokushukai Hospital, Miyagi, Japan. y_kami@me.com.

Takeki Ohashi (T)

Cardiovascular Surgery Department, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho kita, Kasugai City, Aichi, 487-0016, Japan.

Masao Tadakoshi (M)

Cardiovascular Surgery Department, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho kita, Kasugai City, Aichi, 487-0016, Japan.

Akinori Kojima (A)

Cardiovascular Surgery Department, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho kita, Kasugai City, Aichi, 487-0016, Japan.

Hirotaka Yamauchi (H)

Cardiovascular Surgery Department, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho kita, Kasugai City, Aichi, 487-0016, Japan.

Kaoru Hioki (K)

Cardiovascular Surgery Department, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho kita, Kasugai City, Aichi, 487-0016, Japan.

Takanori Hishikawa (T)

Cardiovascular Surgery Department, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho kita, Kasugai City, Aichi, 487-0016, Japan.

Souichirou Kageyama (S)

Cardiovascular Surgery Department, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho kita, Kasugai City, Aichi, 487-0016, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH